Eir Ventures grants one-carbon a convertible loan to continue pre-seed activities in company and at the same time Magnus Persson becomes the new chairman and Alexander Mata joins the board of directors.
Detailed mode of action of the MTHFD1/2 inhibitor TH9619 now published in Nature Metabolism
The One-carbon Therapeutics team is proud and excited to share
